Publications by authors named "Luca Sarcinelli"
Article Synopsis
- - The study aimed to evaluate the role of the post-void residual (PVR) ratio in achieving a favorable trifecta outcome in patients with lower urinary tract symptoms and benign prostatic enlargement who undergo transurethral resection of the prostate (TURP).
- - A total of 143 patients were analyzed, with key assessments including international prostate symptom score (IPSS), uroflowmetry, and prostate volume measurements; 58% of patients achieved a positive trifecta outcome based on specific postoperative criteria.
- - The research concluded that while preoperative IPSS and maximum urinary flow rate (Qmax) are significant predictors of a successful trifecta outcome, the PVR ratio did not demonstrate independent predictive value.
Objective: To identify which medications are mostly associated with ejaculatory disorders through a disproportionality analysis.
Methods: The Food and Drug Administration Adverse Event Reporting System (FDA-FAERS) and the Eudra-Vigilance (EV) database were queried to identify medications more commonly associated to ejaculatory disorders from September 10, 2012 to June 1, 2023. Proportional Reported Ratios (PRRs) were computed for all the selected drugs.
Background: Aim of our study was to analyze adverse events (AEs) associated with darolutamide using real life data from Eudra-Vigilance (EV) and the Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) databases.
Methods: EV database in European Economic Area (EEA) and the FDA FAERS database were queried to identify darolutamide AEs occurred from 30th July 2019 to May 2022. AEs were recorded in according to category and severity.